Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,011 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

NCT04676828

Conditions: Abnormalities, Radiation-Induced, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations: Sydney West Radiation Oncology Network Westmead and Blacktown Hospitals Sydney, New South Wales, Australia

Department of Oncology, Aarhus University Hospital Aarhus, Denmark

View Trial Details

Recruiting

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital

NCT07146568

Conditions: Cancer of the Lung, Lung Cancer, Lung Diseases, +6 more
Locations: Barnes-Jewish Christian Hospital St Louis, Missouri, United States

View Trial Details

Recruiting

Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer

NCT06918132

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Lung Cancer Screening in High-risk Black Individuals

NCT05898594

Conditions: Lung Cancer, Lung Carcinoma, Lung Diseases, +6 more
Locations: University of Chicago Chicago, Illinois, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Recruiting

Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients

NCT07427537

Conditions: Cancer, Lung, Colon Neoplasm, Colonic Diseases, +21 more
Locations: CHU Clermont-Ferrand Clermont-Ferrand, France

View Trial Details

Recruiting

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

NCT05974150

Conditions: Acute Myelogenous Leukemia, Adnexal Diseases, Blood Protein Disorders, +42 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Northshore University Health System Evanston, Illinois, United States

Univeristy of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States

Duke Durham, North Carolina, United States

View Trial Details

Recruiting

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06236438

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Moores Cancer Center /ID# 267782 La Jolla, California, United States

Memorial Hospital West /ID# 262221 Pembroke Pines, Florida, United States

Bond Clinic /ID# 262611 Winter Haven, Florida, United States

University Cancer & Blood Cent /ID# 261824 Athens, Georgia, United States

View all 61 locations

View Trial Details

Recruiting

Precision Lung Cancer Survivorship Care Intervention

NCT05857995

Conditions: Cancer of Lung, Cancer of the Lung, Cancer, Lung, +19 more
Locations: Markey Cancer Center Lexington, Kentucky, United States

View Trial Details

Recruiting

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

NCT05753722

Conditions: Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations: Honor Health Research Institute Scottsdale, Arizona, United States

Yale Cancer Center New Haven, Connecticut, United States

Mass General Cancer Center Boston, Massachusetts, United States

Providence Cancer Institute Franz Clinic Portland, Oregon, United States

View Trial Details

Recruiting

Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment

NCT06830694

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

View Trial Details

Thoracic Neoplasms

Thoracic Neoplasms trial results

Related conditions